Fortress Biotech (FBIO) Intangibles (2015 - 2026)
Fortress Biotech (FBIO) posted quarterly Intangibles of $27.6 million for Q4 2025, down 13.36% year-over-year from $31.9 million in Q4 2024, and down 3.71% quarter-over-quarter from $28.7 million in Q3 2025.
Analysis
Fortress Biotech (FBIO) Intangibles (2015 - 2026) Analysis & Trends
Fortress Biotech's Intangibles history runs 11 years deep, the most recent figure standing at $27.6 million for Q4 2025.
- In Q4 2025, Intangibles fell 13.36% year-over-year to $27.6 million; the TTM figure through Dec 2025 stood at $27.6 million (down 13.36% YoY), while the FY2025 annual figure was $27.6 million, down 13.36% from the prior year.
- Intangibles for Q4 2025 stood at $27.6 million, down from $28.7 million in the prior quarter.
- The five-year high for Intangibles was $31.9 million in Q4 2024, with the low at $397000.0 in Q2 2021.
- The 5-year median for Intangibles is $24.0 million (2023), against an average of $22.1 million.
- The sharpest annual moves came in 2021 and 2022: Intangibles slumped 94.05% in 2021, then soared 7315.62% in 2022.
- Fortress Biotech's Intangibles stood at $12.6 million in 2021, then surged by 116.67% to $27.2 million in 2022, then decreased by 25.41% to $20.3 million in 2023, then jumped by 57.06% to $31.9 million in 2024, then fell by 13.36% to $27.6 million in 2025.
- Business Quant data shows FBIO's Intangibles at $27.6 million in Q4 2025, $28.7 million in Q3 2025, and $29.7 million in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | 266.00 Mn |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | 63.28 Mn |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | 60.96 Mn |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | - |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 93.49 Mn |
| 10 | Fortress Biotech | 86.15 Mn | -110.42 Mn | 12.58 Mn | 25.51 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 25.51 Mn |
| Dec 31, 2025 | 27.61 Mn |
| Sep 30, 2025 | 28.67 Mn |
| Jun 30, 2025 | 29.73 Mn |
| Mar 31, 2025 | 30.80 Mn |
| Dec 31, 2024 | 31.86 Mn |
| Sep 30, 2024 | 17.84 Mn |
| Jun 30, 2024 | 18.66 Mn |
| Mar 31, 2024 | 19.47 Mn |
| Dec 31, 2023 | 20.29 Mn |
| Sep 30, 2023 | 21.10 Mn |
| Jun 30, 2023 | 21.92 Mn |
| Mar 31, 2023 | 26.13 Mn |
| Dec 31, 2022 | 27.20 Mn |
| Sep 30, 2022 | 28.42 Mn |
| Jun 30, 2022 | 29.44 Mn |
| Mar 31, 2022 | 30.46 Mn |
| Dec 31, 2021 | 397,000.00 |
| Sep 30, 2021 | 397,000.00 |
| Jun 30, 2021 | 397,000.00 |